The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology ...
Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
TSHA-102 granted Breakthrough Therapy designation by FDAFinalized FDA alignment on REVEAL pivotal trial protocol and SAP, including 6-month ...
Can artificial intelligence function as a partner in scientific discovery, capable of generating novel, testable hypotheses ...
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...
Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...
Fungi’s evolutionary roots stretch far deeper than once believed — up to 1.4 billion years ago, long before plants or animals ...
ICH gives CGT developers a regulatory framework that finally matches the speed and flexibility their groundbreaking therapies ...
Lamine Yamal (left) and Jude Bellingham headline today’s gossip. / Catherine Steenkeste/Steve Limentani/ISI Photos/ISI Photos via Getty Images Sports Illustrated rounds up the latest transfer rumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback